Abstract
The perspective of the people of Sub-Saharan Africa (SSA) toward both traditional and
western healthcare systems varies. The goal of the current study is to examine the SSA's unique skin
disease health care system. This study comprises numerous research that sought to examine how the
general public feels about the SSA's current healthcare system. In this review, common skin conditions,
such as atopic dermatitis, buruli ulcers, dermatophytosis, and scabies, are addressed. According
to this report, government agencies must pay particular attention to skin illnesses in SSA and raise
public awareness. Availability of medical care, socioeconomic factors, degree of education, and other
factors influence patients’ attitudes toward traditional and western health care differently in different
geographic areas. Facts suggest that self-medication is the preference of the majority of patients before
seeking dermatological care. The present study concludes that the magnitude of skin diseases is neglected
or underestimated in many regions of SSA. Also, western healthcare facilities of many regions
of SSA are not up to the mark. The present study recommends that proper access to the health care
system and awareness about skin diseases through various government programs can be helpful in the
regulation of skin disorders among people of SSA.
Keywords:
Skin disease, sub-saharan Africa, western health care, traditional medicines, skincare, sub-saharan health care systems.
Graphical Abstract
[2]
Mokgobi M. Health Care Practitioners’ Attitudes towards Traditional African Healing. Altern Complement Integr Med (Encinitas) 2016; 3: 1-5.
[7]
Gurib-Fakim A, Brendler T, Phillips LD, Eloff JN. Green Gold: Success stories using southern african medicinal plant species. Association of african medicinal plants standards. 2010.
[15]
Busia K, Kasilo OM. Collaboration between traditional health practitioners and conventional health practitioners: some country experiences. Afr Health Monit 2010; 13: 40-6.
[17]
Dlamini PS. Facilitating collaboration between traditional healers and western health practitioners in the management of chronic illnesses in Swaziland [dissertation]. South Africa: University of Natal 2001.
[28]
Elujoba AA. Review of the book “African Herbal Pharmacopoeia” association for African medicinal plants standards. Afr J Tradit Complement Altern Med 2012; 9: 81-2.
[32]
Rohra DK, Mustafa OM. Patterns and determinants of self-medication among university students in Saudi Arabia. JPHS 2017; 8: 177-85.
[35]
Roderick H, Bendeck SE, Chen S, et al. Disease Control Priorities in developing countries: The International Bank for Reconstruction and Development. New York: Oxford University Press 2006; 2: p. 37.
[36]
Schmidt H. Chronic Disease Prevention and Health Promotion.In: Public Health Ethics: Cases Spanning the Globe. Cham: Springer International Publishing 2016; pp. 137-76.
[61]
Giselle M, Mariya M. Hair and Scalp Infections.In: Hair Pathology with Trichoscopic Correlations Airstream. Elsevier 2019; pp. 207-18.
[63]
Souissi A, Zeglaoui F, Zouari B, Kamoun MR. A study of skin diseases in Tunis. An analysis of 28,244 dermatological outpatient cases. Acta dermatovenerologicaAlpina, Pannonica. Adriat 2007; 16: 111-6.
[70]
Rook A, Savin JA, Wilkinson DS. The prevalence, incidence and ecology of diseases of the skin Textbook of Dermatology. Palo Alto: Blackwell Scientific Publications 1986; pp. 39-53.
[88]
"Drug Approval Package: Skyrizi". U.S. Food and Drug Administration (FDA). 30 May 2019. Retrieved 08 October 2020.
[107]
Retsky JE, Kraft C. The extraintestinal manifestations of inflammatory bowel disease Inflammatory Bowel Disease. (4th ed.). Baltimore, Md, USA: Williams & Wilkins 1995; p. 47.
[136]
Zoung-Kanyi Bissek AC. Ntone Ef, Mboua BJ, et al. Clinique et vécu de l’acné chez l’adulte. Health Sci Dis 2008; 9: 46-9.
[160]
Diallo S, Thiongane C, Victorius A. Les teignes du cuir cheveluau Senegal oriental: Etude en milieu scolaire a Tambacounda. Med Afr Noire 1985; 32: 495-503.
[164]
Ak MA. Comprehensive review of acne vulgaris. J Clin Pharmacol 2019; 1: 17-45.
Download PDF Flyer